These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11016718)

  • 21. Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement.
    de Kanter AY; Menke-Pluijmers MB; Henzen-Logmans SC; van Geel AN; van Eijck CJ; Wiggers T; Eggermont AM
    Eur J Surg Oncol; 2006 Jun; 32(5):498-501. PubMed ID: 16580810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of axillary lymph-node metastases in patients with pure tubular carcinoma of the breast and sentinel node biopsy.
    Leikola J; Heikkilä P; von Smitten K; Leidenius M
    Eur J Surg Oncol; 2006 Jun; 32(5):488-91. PubMed ID: 16569494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sentinel lymph node biopsy in breast cancer: the Lausanne experience].
    Delaloye JF; Antonescu C; Besseghir N; Genton CY; Bischof-Delaloye A; De Grandi P
    Rev Med Suisse Romande; 2000 Jun; 120(6):491-4. PubMed ID: 11014092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel lymph node biopsy in breast cancer: the GIVOM experience in Veneto, Italy.
    Zavagno G; Meggiolaro F; Bozza F; Scalco G; Racano C; Rubello D; Pescarini L; De Salvo G; Lise M
    Tumori; 2002; 88(3):S52-4. PubMed ID: 12369554
    [No Abstract]   [Full Text] [Related]  

  • 27. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel lymph node drainage in multicentric breast cancers.
    Jin Kim H; Heerdt AS; Cody HS; Van Zee KJ
    Breast J; 2002; 8(6):356-61. PubMed ID: 12390358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential and pitfalls of sentinel node detection in breast cancer.
    Chu KU; Giuliano AE
    Recent Results Cancer Res; 2000; 157():237-49. PubMed ID: 10857177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel node detection in breast carcinoma.
    Pelosi E; Arena V; Baudino B; Bellò M; Giani R; Lauro D; Ala A; Bussone R; Bisi G
    Tumori; 2002; 88(3):S10-1. PubMed ID: 12365369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different sites and modes of tracer injection for mapping the sentinel lymph node in patients with breast cancer.
    Bianchi P; Villa G; Buffoni F; Agnese G; Gipponi M; Costa R; Maragliano C; Canavese G; Mariani G
    Tumori; 2000; 86(4):307-8. PubMed ID: 11016710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of sentinel lymph node in breast cancer: our experience in 46 cases.
    Galli A; Massaza L; Chiappo L; Paduos A; Rosso G
    Tumori; 2000; 86(4):317-9. PubMed ID: 11016714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials.
    Wallace AM; Han LK; Povoski SP; Deck K; Schneebaum S; Hall NC; Hoh CK; Limmer KK; Krontiras H; Frazier TG; Cox C; Avisar E; Faries M; King DW; Christman L; Vera DR
    Ann Surg Oncol; 2013 Aug; 20(8):2590-9. PubMed ID: 23504141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node mapping opens a new perspective in the surgical management of early-stage breast cancer: a combined approach with vital blue dye lymphatic mapping and radioguided surgery.
    Canavese G; Gipponi M; Catturich A; Di Somma C; Vecchio C; Rosato F; Tomei D; Cafiero F; Moresco L; Nicolò G; Carli F; Villa G; Buffoni F; Badellino F
    Semin Surg Oncol; 1998 Dec; 15(4):272-7. PubMed ID: 9829386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of lymphoscintigraphic mapping with Tc-99m human serum albumin and tin colloid in sentinel lymph node biopsy in breast cancer.
    Kim R; Osaki A; Kojima J; Toge T
    Int J Oncol; 2001 Nov; 19(5):991-6. PubMed ID: 11604999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
    van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.
    Borgstein PJ; Pijpers R; Comans EF; van Diest PJ; Boom RP; Meijer S
    J Am Coll Surg; 1998 Mar; 186(3):275-83. PubMed ID: 9510258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel lymph node biopsy in the treatment of breast cancer. Experience in 527 cases.
    Procaccini E; Ruggiero R; Docimo G; Iovino F; Procaccini F; De Luca R; Irlandese E; Gili S; Lo Schiavo F
    Minerva Chir; 2007 Apr; 62(2):93-9. PubMed ID: 17353851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel lymph node biopsy in breast cancer: review on various methodological approaches.
    Zengel B; Yararbas U; Sirinocak A; Ozkok G; Denecli AG; Postaci H; Uslu A
    Tumori; 2013; 99(2):149-53. PubMed ID: 23748806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sentinel node biopsy in T2 breast cancers larger than 3 cm and clinically negative axilla compared with the T1-T2 <3 cm standard indication].
    Ruano R; Ramos M; García-Talavera JR; García Macías MC; Martín de Arriba A; González-Orús JM; Iglesias M; Serrano E
    Rev Esp Med Nucl; 2008; 27(3):176-82. PubMed ID: 18570859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.